These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 25183445)

  • 1. [Reduction of animal experiments in experimental drug testing].
    Behrensdorf-Nicol H; Krämer B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1173-80. PubMed ID: 25183445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of transgenic animals in biomedical research in Germany. Part 2: Ethical evaluation of the use of transgenic animals in biomedical research and perspectives for the changeover in research to research animal-free methods].
    Sauer UG; Kolar R; Rusche B
    ALTEX; 2006; 23(1):3-16. PubMed ID: 16477343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternatives to animal experimentation in basic research.
    Gruber FP; Hartung T
    ALTEX; 2004; 21 Suppl 1():3-31. PubMed ID: 15586255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 3Rs and animal welfare - conflict or the way forward?
    Rusche B
    ALTEX; 2003; 20(Suppl 1):63-76. PubMed ID: 14671703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Official testing of immunological veterinary medicinal products].
    Jungbäck C; Motitschke A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1193-7. PubMed ID: 25168840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Animal experiments: legal, scientific and ethical aspects].
    Houvenaghel A
    Verh K Acad Geneeskd Belg; 2000; 62(2):103-17. PubMed ID: 10818819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three Rs potential in the development and quality control of pharmaceuticals.
    Hartung T
    ALTEX; 2001; 18 Suppl 1():3-13. PubMed ID: 11854852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress in the replacement of animal experiments in the quality control of clostridial vaccines].
    Cussler K; Borrmann E; Werner E
    Dtsch Tierarztl Wochenschr; 2002 Apr; 109(4):172-7. PubMed ID: 11998369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Testing of vaccines. The challenge of testing complex combination vaccines].
    Merkle A; Lechner H; Oppling V; Meyer H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1188-92. PubMed ID: 25204275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental testing of centrally authorised medicinal products. The CAP programme].
    Giess S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1169-72. PubMed ID: 25159224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Testing of medicinal products produced from pooled plasma].
    Unkelbach U; Hunfeld A; Breitner-Ruddock S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1181-4. PubMed ID: 25213735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ahimsa and alternatives -- the concept of the 4th R. The CPCSEA in India.
    Pereira S; Tettamanti M
    ALTEX; 2005; 22(1):3-6. PubMed ID: 15719144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Official experimental testing of biomedical products. Regulatory frame and importance of for quality, safety and efficacy].
    Vieths S; Seitz R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1133-8. PubMed ID: 25123139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Directive 86/609/EEC on the protection of animals used for experimental and other scientific purposes.
    Louhimies S
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():217-9. PubMed ID: 12513679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refinement, reduction, and replacement of animal use for regulatory testing: future improvements and implementation within the regulatory framework.
    Richmond J
    ILAR J; 2002; 43 Suppl():S63-8. PubMed ID: 12388854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ECVAM: desperately needed or superfluous? An animal welfare perspective.
    Kolar R
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():169-74. PubMed ID: 12513669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of the 3Rs (refinement, reduction, and replacement): validation and regulatory acceptance considerations for alternative toxicological test methods.
    Schechtman LM
    ILAR J; 2002; 43 Suppl():S85-94. PubMed ID: 12388858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards eliminating the use of animals for regulatory required vaccine quality control.
    Hendriksen CF
    ALTEX; 2006; 23(3):187-90. PubMed ID: 17086348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The EDQM Biological Standardisation Programme for the development of methods and reference preparations].
    Buchheit KH; Seitz R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1152-7. PubMed ID: 25112952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.